Therefore, the purpose of this scoping review is to characterize the current evidence base for peptide therapies relevant to musculoskeletal care, with emphasis on BPC-157, thymosin beta-4 derivatives, and related agents, and to define safety considerations and perioperative implications for orthopaedic surgical patients, including those undergoing TJA
As UK scientific research continues to unveil the transformative potential of peptide therapy, the future of longevity and vitality looks increasingly promising
A decrease in LAV was observed in the HFrEF population (WMD: -5.4 ml [95% CI: -8.8, -2.0]
CREB: cAMP response element binding-protein
AOD-9604 vs GLP-3 RT GLP-3 RT (retatrutide) adds a third receptor target glucagon on top of the GIP/GLP-1 combination, representing the broadest incretin-pathway approach among compounds referenced in this comparison